NeXtGen Biologics @nextgenbiologic - Twitter Profile

4 months ago

Wild axolotls have incredibly low cancer rates even when living in polluted waters. Studies show they resist chemical carcinogens that would cause tumors. The Genetic Odyssey of Axolotl Regeneration: Insights and Innovations | The International Journal of Developmental Biology

0

6

NeXtGen Biologics @NeXtGenBiologic

4 months ago

The term "Neoteny" was actually made for axolotls. It was coined by German researcher, Julius Kollman, in 1884 to describe the anti-aging properties of the creatures, showing that axolotls have been studied for their unique properties for over a century!

NeXtGenBiologic's tweet photo. The term "Neoteny" was actually made for axolotls. It was coined by German researcher, Julius Kollman, in 1884 to describe the anti-aging properties of the creatures, showing that axolotls have been studied for their unique properties for over a century! https://t.co/uSrTEB7oea

0

5

NeXtGen Biologics @NeXtGenBiologic

4 months ago

How do you regenerate tissues w/o triggering cancer? Axolotl cells dedifferentiate, proliferate, and redifferentiate—a process researchers aim to replicate. The Genetic Odyssey of Axolotl Regeneration: Insights and Innovations | The International Journal of Developmental Biology

0

7

NeXtGen Biologics @NeXtGenBiologic

5 months ago

Thousands of articles ask, “What if?” What if wound closure could be approached differently? What if regenerative science unlocked new possibilities? What if solutions inspired by nature could inform the future of medicine? It’s not Sci‑Fi. It’s not AI. It’s NeXtGen!

0

8

Who to follow

Biotility

@biotility

Biotility at the University of Florida is a national leader in high-quality credentialing and professional development for the bioscience industries.

UF Pathways

@UFPathways

UF Innovate | Pathways serves to empower innovators with training and resources to support innovation and commercialization at @UF - Check out @UFCollaboratory

UF Innovate | Ventures

@UFVentures

We seek to fuel consistent growth in the number and quality of technology-based startup companies licensing UF technologies.

NeXtGenBiologic retweeted

UF Innovate | Accelerate @UFAccelerate

6 months ago

Great news from @UFAccelerate client company @NeXtGenBiologic!💡 The @uspto declined to review its wound care patents after a challenge from a former licensee, keeping its NeoMatriX® Wound Matrix fully protected! Learn more: https://t.co/WRQLd8m6mz